Georgia Pepe

Georgia Pepe

Auto-generated profile, based on publicly available information

Georgia Pepe

Genekor Medical S.A. Athens Greece

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2026 in Epileptic Disorders
Verified
Journal Article
Open access
PDF file
SKStefania Kalampokini
Stefania Kalampokini
EPEvripidis Pityrigkas
Evripidis Pityrigkas
ZKZoi Kallia
Zoi Kallia
GPGeorgia Pepe
Georgia Pepe
AFAntonis Frontistis
Antonis Frontistis
VKVasilios Kimiskidis
Vasilios Kimiskidis
Background and Objectives: KBG syndrome is a rare autosomal developmental disorder caused by pathogenic variants of the ANKRD11 gene. This scoping review aimed to explore all current literature data regarding clinical and electroencephalographic features of patients with KBG syndrome and epilepsy. Materials and Methods: We conducted a literature review of previously published cases of patients with KBG syndrome and epilepsy in PubMed, Scopus, and Web of Science databases in English, focusing on seizure semiology and electroencephalographic features. Results: Fifty‐four studies were included in the review, including 233 patients with KBG syndrome and epilepsy. Most children with KBG syndrome and epilepsy (89.7%) had developmental delay and intellectual disability. The most common neurological symptoms were hypotonia (30.7%), sleep disturbances (20%), ataxia (18.7%), migraine (8.3%), and stereotypies (6.7%) ( N = 75, available data on neurological symptoms). The median age of developing seizures was 4 years (range 1 month–51 years). Patients with KBG syndrome had most commonly generalized seizures (73.9%), although focal seizures occurred in 37.9% of cases ( N = 140, available data on seizure type). Generalized tonic–clonic seizures were the most common seizure type (38.2%), followed by absences (26.6%), and focal seizures with or without preserved consciousness (21.9% and 19.1%, respectively). Interictal EEG showed focal and, less frequently, generalized discharges (24.6% vs. 15%) in the 118 patients with available EEG data. Almost 70% of patients were seizure‐free after a mean follow‐up of 9.9 years, while drug‐resistant epilepsy was reported in 22.6% of cases. Patients with focal impaired consciousness seizures had significantly lower odds of achieving seizure freedom. Conclusion: Epileptic seizures in patients with KBG syndrome are usually generalized and have an onset between infancy and mid‐teens. Common epileptological features in KBG syndrome comprise the good response to antiseizure medication and, in most cases, the remitting nature of epilepsy. Drug‐resistant epilepsy can be observed in up to one‐third of cases.